Proacta S.A. (WSE:PAC)

Poland flag Poland · Delayed Price · Currency is PLN
0.818
+0.042 (5.41%)
At close: Feb 27, 2026
-9.11%
Market Cap 96.05M
Revenue (ttm) 6.54M
Net Income (ttm) -4.99M
Shares Out 117.43M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 40,011
Average Volume 24,765
Open 0.818
Previous Close 0.776
Day's Range 0.730 - 0.818
52-Week Range 0.700 - 1.445
Beta -0.27
RSI 38.42
Earnings Date Feb 13, 2026

About Proacta

Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. The company offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; DBCU, an innovative platform using advanced technologies to optimize the breast cancer treatment process; and Patient Portal, an innovative tool for monitoring health, managing medical data, and supporting the treatment process. It also provides AI/ML services... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services
Founded 2015
Employees 14
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PAC
Full Company Profile

Financial Performance

In 2024, Proacta's revenue was 3.12 million, an increase of 380.99% compared to the previous year's 647,669. Losses were -9.54 million, 862.8% more than in 2023.

Financial Statements

News

There is no news available yet.